In conclusion, Nedd5 is a novel autoantigen of potential clinical importance that could be successfully used for a more thorough investigation of the pathogenesis of psychiatric manifestations in SLE. This evidence concerns the gene SEPTIN2 and systemic lupus erythematosus.